Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A

SSZSE:301211
10.00
CNY
-0.15
(-1.48%)
0.13EPS
101.45P/E
5.30BMarket Cap

Latest Stock Split

Aug 27, 2025

29:20

For every 20 shares held, investors received 29. The price per share adjusted from $18.84 to $12.99.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Aug 27, 2025
    Before$18.84
    Split ratio29:20
    After$12.99
    Forward
  2. May 31, 2023
    Before$32.75
    Split ratio6:5
    After$27.29
    Forward

About Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A stock splits

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A (SZSE:301211) operates in the Pharmaceuticals: major industry.

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A company overview

When did Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A stock split?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A's most recent stock split was on August 27, 2025. It was a 29-for-20 forward split, so shareholders received 29 shares for every 20 they held.

What is Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A's stock split history?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A (SZSE:301211) has split its stock 2 times: a 6-for-5 split on May 31, 2023 and a 29-for-20 split on August 27, 2025.

How many times has Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A stock split?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between May 31, 2023 and August 27, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A's 29-for-20 split on August 27, 2025, every 20 shares became 29 shares.

Will Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A split its stock again?

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on August 27, 2025, 1 year ago. Companies announce splits in advance, and any new SZSE:301211 split will appear on this page.